A round-up of all the biotech news dumped Friday night while you were heading off for Memorial Day weekend festivities!
$SGMO $200M mixed shelf https://t.co/Dm3RBSa8Fz
— Odi Bruckman (@odibro) May 26, 2017
$TGTX $300M ATM with 7 banks. That has to be a record.
— Adam Feuerstein (@adamfeuerstein) May 26, 2017
$IPCI $100m mixed shelf
— Shane Blackmon (@shaneblackmon) May 26, 2017
$SGMO $75m ATM offering through Cowen
— Shane Blackmon (@shaneblackmon) May 26, 2017
$CYCC $15M offering
— Odi Bruckman (@odibro) May 26, 2017
$NWBO on precipice of financial insolvency. Can’t pay off debt. 8-K filed Friday before Memorial Day, of course https://t.co/EhVKxAu4za
— Adam Feuerstein (@adamfeuerstein) May 26, 2017
- Imprimis Pharma files S-3 $IMMY
- BeiGene prospectus for selling shareholders $BGNE
- Synergy Pharma CSO departure $SGYP
- ContraVir Pharma new deal with CEO $CTRV
- Trillium Therapeutics supplemental prospectus (and underwriting agreement) $TRIL
- Generex Biotechnology terminates COO $GNBT
- Anavex Life Sciences files S-3 $AXVL
- Rexahn Pharma files S-3 $RNN
- Regulus Therapeutics new deal with CFO $RGLS
- Diffusion Pharmaceuticals receives NASDAQ delisting notice $DFFN
RSS Feed
